ATE220110T1 - Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen - Google Patents

Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen

Info

Publication number
ATE220110T1
ATE220110T1 AT97921143T AT97921143T ATE220110T1 AT E220110 T1 ATE220110 T1 AT E220110T1 AT 97921143 T AT97921143 T AT 97921143T AT 97921143 T AT97921143 T AT 97921143T AT E220110 T1 ATE220110 T1 AT E220110T1
Authority
AT
Austria
Prior art keywords
reagants
assay
active ingredients
fungicidal active
relates
Prior art date
Application number
AT97921143T
Other languages
English (en)
Inventor
Vivian Berlin
David E Levin
Yoshikazu Ohya
Original Assignee
Mitotix Inc
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/631,319 external-priority patent/US6117641A/en
Application filed by Mitotix Inc, Univ Johns Hopkins filed Critical Mitotix Inc
Application granted granted Critical
Publication of ATE220110T1 publication Critical patent/ATE220110T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/9116—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • G01N2333/91165—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1)
AT97921143T 1996-04-11 1997-04-11 Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen ATE220110T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/631,319 US6117641A (en) 1996-04-11 1996-04-11 Assays and reagents for identifying anti-fungal agents and uses related thereto
US08/771,212 US6455281B1 (en) 1996-04-11 1996-12-20 Nucleic acids for identifying anti-fungal agents, and uses related thereto
PCT/US1997/005987 WO1997038293A2 (en) 1996-04-11 1997-04-11 Assays and reagents for identifying anti-fungal agents, and uses related thereto

Publications (1)

Publication Number Publication Date
ATE220110T1 true ATE220110T1 (de) 2002-07-15

Family

ID=27091358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97921143T ATE220110T1 (de) 1996-04-11 1997-04-11 Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen

Country Status (9)

Country Link
US (2) US6271197B1 (de)
EP (1) EP0892854B1 (de)
JP (1) JP2001513622A (de)
KR (1) KR20000005397A (de)
AT (1) ATE220110T1 (de)
AU (1) AU717165B2 (de)
CA (1) CA2251593A1 (de)
DE (1) DE69713759T2 (de)
WO (1) WO1997038293A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117641A (en) 1996-04-11 2000-09-12 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents and uses related thereto
US6727082B1 (en) 1996-04-11 2004-04-27 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
JP2001513622A (ja) 1996-04-11 2001-09-04 マイトティックス インコーポレーテッド 抗菌剤の同定のためのアッセイおよび試薬、並びにそれらに関連する利用
AU4858597A (en) * 1996-10-30 1998-05-22 National Research Council Of Canada (candida albicans) proteins associated with virulence and hyphal formation and uses thereof
JPH11103862A (ja) * 1997-10-01 1999-04-20 Takara Shuzo Co Ltd 抗原タンパク質及び該タンパク質をコードする核酸
EP1062344A2 (de) * 1998-03-13 2000-12-27 Mitotix, Inc. Assays und reagenzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen
US6423519B1 (en) 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
US6720139B1 (en) * 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
US6589738B1 (en) * 1999-11-09 2003-07-08 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation and antisense thereto
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
US20030180953A1 (en) * 2000-12-29 2003-09-25 Elitra Pharmaceuticals, Inc. Gene disruption methodologies for drug target discovery
EP1390468A4 (de) * 2001-04-23 2004-09-22 Elitra Pharmaceuticals Inc Identifizierung essentieller gene von aspergillus fumigatus und verwendungsverfahren
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US20030170694A1 (en) * 2001-12-21 2003-09-11 Daniel Wall Stabilized nucleic acids in gene and drug discovery and methods of use
CA2492074A1 (en) * 2002-07-10 2004-01-15 Stratagene Humanized renilla reniformis green fluorescent protein as a scaffold
KR100914749B1 (ko) 2002-12-31 2009-08-31 엘지디스플레이 주식회사 구동회로를 포함하는 반사형 액정 표시 장치

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59212439A (ja) 1983-05-19 1984-12-01 Taisho Pharmaceut Co Ltd スチレン誘導体
JP2971894B2 (ja) * 1988-08-10 1999-11-08 武田薬品工業株式会社 Ｃ―キナーゼの酵母による製造法
WO1991013988A1 (en) 1990-03-15 1991-09-19 The Board Of Regents, The University Of Texas System RECOMBINANT β-1,4 GLUCAN SYNTHASE PROTEINS
US5202456A (en) 1991-04-15 1993-04-13 The President And Fellows Of Harvard College Compounds for inhibition of protein methylation
IL99628A (en) 1991-10-02 2004-07-25 Yissum Res Dev Co Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them
ATE129407T1 (de) 1991-10-11 1995-11-15 Squibb & Sons Inc Verwendung von biphosphonaten zur herstellung eines arzneimittels zur blockierung neoplastischer zelltransformationen die durch ras-oncogene verursacht werden.
AU4676393A (en) 1992-07-14 1994-01-31 President And Fellows Of Harvard College Compounds for inhibition of proteolysis
GB9226065D0 (en) 1992-12-14 1993-02-10 Ici Plc Peptides
US5602184A (en) 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
EP0621342A1 (de) 1993-04-20 1994-10-26 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Reagenz und Testsatz zum Nachweis oder zur Hemmung von isoprenylierender Aktivität
EP0763537A3 (de) 1993-05-14 1997-10-22 Genentech Inc Nichtpeptide Farnesyltransferas Inhibitoren
IL109615A (en) 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5602098A (en) 1993-05-18 1997-02-11 University Of Pittsburgh Inhibition of farnesyltransferase
US5705686A (en) 1993-05-18 1998-01-06 University Of Pittsburgh Inhibition of farnesyl transferase
EP0724644B1 (de) * 1993-10-12 2003-12-03 Merck & Co. Inc. Für die untereinheiten der 1,3-beta-d-glucansynthase kodierende dna
IL111235A (en) 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5721236A (en) 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
ATE200677T1 (de) 1993-10-25 2001-05-15 Parke Davis & Co Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
IL107587A (en) 1993-11-12 1998-08-16 Univ Ramot Farnesyl geranyl or geranyl-geranyl derivatives pharmaceutical compositions containing them and methods for their preparation
US5539132A (en) 1994-01-24 1996-07-23 Johns Hopkins University Cerulenin compounds for fatty acid synthesis inhibition
US5470832A (en) 1994-01-31 1995-11-28 Merck & Co., Inc. Inhibitors of geranylgeranyl-protein transferase
AU2122795A (en) 1994-03-15 1995-10-03 Eisai Co. Ltd. Isoprenyl transferase inhibitors
US5580979A (en) 1994-03-15 1996-12-03 Trustees Of Tufts University Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
CA2143588A1 (en) 1994-03-24 1995-09-25 Rajeev Bhide Inhibitors of farnesyl protein transferase
US5510510A (en) 1994-05-10 1996-04-23 Bristol-Meyers Squibb Company Inhibitors of farnesyl protein transferase
US5541181A (en) 1994-05-26 1996-07-30 Bristol-Myers Squibb Company Compound produced by a strain of micromonospora
US5484724A (en) 1994-05-26 1996-01-16 Merck & Co., Inc. DNA encoding GLSI
US5574025A (en) 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
WO1996017623A1 (en) 1994-12-09 1996-06-13 Banyu Pharmaceutical Co., Ltd. Anti-aids drug
CA2207252C (en) 1995-01-12 2014-02-25 University Of Pittsburgh Inhibitors of prenyl transferases
US5684013A (en) 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5624936A (en) 1995-03-29 1997-04-29 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL117797A0 (en) 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
DE69620292T2 (de) 1995-05-31 2002-11-21 Shell Int Research Copolyester Zusammensetzung
US5723686A (en) 1995-08-03 1998-03-03 Phillips Petroleum Company Recycle of alcohol in a combined hydroisomerization and etherification process
GB2306646A (en) 1995-10-30 1997-05-07 Merck & Co Inc Assay for compounds which inhibit ras oncogene activity involving farnesyl-protein transferase
JP4533466B2 (ja) 1995-11-06 2010-09-01 ユニバーシティ オブ ピッツバーグ 蛋白質イソプレニルトランスフェラーゼの阻害剤
CA2238081A1 (en) 1995-11-22 1997-05-29 S. Jane Desolms Inhibitors of farnesyl-protein transferase
IT1276162B1 (it) 1995-11-23 1997-10-27 Baldacci Lab Spa Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
JP2001503963A (ja) 1996-02-06 2001-03-27 イーライ・リリー・アンド・カンパニー 糖尿病治療
US6011029A (en) 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
JP2001513622A (ja) 1996-04-11 2001-09-04 マイトティックス インコーポレーテッド 抗菌剤の同定のためのアッセイおよび試薬、並びにそれらに関連する利用
EP0952842A2 (de) 1996-04-18 1999-11-03 Merck & Co., Inc. Verfahren zur behandlung von krebs

Also Published As

Publication number Publication date
CA2251593A1 (en) 1997-10-16
AU717165B2 (en) 2000-03-16
WO1997038293A3 (en) 1997-12-04
EP0892854B1 (de) 2002-07-03
KR20000005397A (ko) 2000-01-25
US6277564B1 (en) 2001-08-21
DE69713759D1 (de) 2002-08-08
EP0892854A2 (de) 1999-01-27
US6271197B1 (en) 2001-08-07
DE69713759T2 (de) 2003-03-13
WO1997038293A2 (en) 1997-10-16
JP2001513622A (ja) 2001-09-04
AU2726597A (en) 1997-10-29

Similar Documents

Publication Publication Date Title
ATE220110T1 (de) Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen
DE69935314D1 (de) Quantitatitative bestimmung von nucleinsäure-amplifizierungsprodukten
Grossman et al. E6 protein of human papillomavirus type 18 binds zinc
DE69517010T2 (de) Ubiquitin-konjugierende enzyme
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
WO2000004389A3 (en) Arrays of protein-capture agents and methods of use thereof
EP1780264A3 (de) Nukleinsäurenematizide
DE69831083D1 (de) Reprimiertes trans-aktivatorsystem zur charakterisierung von protein-protein interaktionen
HUP0103601A2 (hu) Hízósejtek degranulációját gátló hibrid protein és alkalmazása
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
ATE380249T1 (de) Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen
ATE267396T1 (de) Identifizierung von zellen während kinetischer versuchsreihen
WO2002063271A3 (en) Activity based probe analysis
AU5143099A (en) Protein fragment complementation assays for the detection of biological or drug interactions
WO2000068414A3 (en) Whole cell assay for cathepsin k
WO2001056456A3 (en) Methods and compositions for detection of disease
WO2003034025A3 (en) Methods and reagents for improved cell-based assays
DE3889718D1 (de) Maltooligosaccharid-Derivate und -Reagenzien für die Bestimmung von Amylase-Aktivität.
WO1999046286A3 (en) Assays and reagents for identifying anti-fungal agents, and uses related thereto
WO1999011799A3 (en) Human aminopeptidase p gene
DE59813664D1 (de) Verfahren zum screening von antimykotisch wirkenden substanzen
DE59814032D1 (de) Nucleinsäuremolekül, kit und verwendung
ATE434936T1 (de) Tsg101-gag-wechselwirkung und ihre verwendung
SE9900615L (sv) Metod och kit för tidig förutsägelse av cancer
WO2003040390A3 (en) Protease assay for therapeutic drug monitoring

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties